过敏煎合小青龙汤加减治疗季节性变应性鼻炎的疗效观察

February 1, 2026

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research explores the clinical efficacy of modified Xiaoqinglong decoction in treating seasonal allergic rhinitis.
Prospective inclusion of 132 patients with seasonal allergic rhinitis from February 2023 to July 2024.
Patients were randomly assigned to a control group (Budesonide treatment) and an observation group (modified Xiaoqinglong decoction), each with 66 patients.
Both groups underwent treatment for 4 weeks with comparisons made on inflammatory factors and symptom improvement.
IL-4 levels were lower and IL-12 levels were higher post-treatment compared to pre-treatment, with significant differences between groups (P<0.05).
Symptom scores for nasal congestion, rhinorrhea, pruritus, and sneezing showed significant improvement in the observation group compared to the control group post-treatment (P<0.05).
The total effective rate of treatment was significantly higher in the observation group than the control group (P<0.05).

We only have this paper's title and publication details.

Demonstrates improved symptoms in seasonal allergic rhinitis patients using modified Xiaoqinglong decoction, indicating effective treatment options.

No takes yet. Share an insight, caveat, or question.

孙 et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share